Skip to content
Search

Latest Stories

England’s new Chief Pharmaceutical Officer praises work of community pharmacy

The newly appointed Chief Pharmaceutical Officer (CPhO) for England, David Webb has set out his personal priorities for the next few years to support the community pharmacy in achieving the shared ambitions at national and local level.

In his keynote speech in person at the National Meeting of LPCs and PSNC, David thanked community pharmacy teams for their work throughout the pandemic to support their local communities and reflected on the many achievements so far.


He said that he intends to be the CPhO “for all members of the two pharmacy professions, in all parts of the NHS.”

“Colleagues in community pharmacy have emphatically shown you are part of the NHS team and delivered as a sector, and that this has further enhanced your credibility in terms of how we continue to integrate pharmacy into the NHS and pathways of care,” said the CPhO.

David went on to give an overview of Integrated Care Systems (ICSs) and outlined the support that will be available for community pharmacy in an ICS. He also went into some detail about the role and responsibilities of the new ICS Community Pharmacy Clinical Leads, whose role will be to:

  • Support the integration of community pharmacy clinical services into ICSs as part of recognised NHS pathways;
  • support community pharmacies to effectively engage with Primary Care Networks (PCNs); and
  • drive mobilisation within local systems to support the scaling and embedding of new clinical services that are developed through the Pharmacy Integration Fund (PhIF) pilots and then into the Community Pharmacy Contractual Framework (CPCF) commissioned services.

“The next few years are pivotal to the profession and we need to ensure the right close working relationship are in place nationally, at system level and locally, if we are to achieve all our ambitions,” he stated.

David’s speech was welcomed by the LPCs who attended the meeting who said that it was great to hear directly from the CPhO about his positive plans for the future of the sector.

James Wood, PSNC’s director of contractor and LPC support, also commented: “It is clear that David appreciates the phenomenal efforts of community pharmacy teams throughout the pandemic and the value of community pharmacy to the nation’s health. PSNC looks forward to working with David on shared ambitions in the months and years ahead to ensure that our joint vision for the sector becomes a reality.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less